Cardlytics (CDLX) PT Raised to $160 at Craig-Hallum
Craig-Hallum analyst Jason Kreyer raised the price target on Cardlytics (NASDAQ: CDLX) to $160.00 (from $145.00) while maintaining a Buy rating.
You May Also Be Interested In
- UPDATE: Needham & Company Starts Cardlytics (CDLX) at Buy
- China Telecom Corp. (728:HK) (CHA) PT Raised to HK$3.80 at Morgan Stanley
- Lindt & Spruengli (LISN:SW) (LDSVF) PT Raised to CHF106,000 at UBS
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!